Pay in 4 interest-free payments of $25.25 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
Y-27632 primes human induced pluripotent stem cells (hIPSCs) to selectively differentiate towards mesendodermal lineage via epithelial-mesenchymal transition-like modulation
The cell lysis buffers used are much stronger than the RIPA buffer
Empagliflozin (BI 107730 is a selective sodium glucose cotransporter-2 (SGLT-2) inhibitor with an IC50 of 3
Dorsomorphin can reverse autophagy activation and anti-inflammatory effect of Urolithin A (HY-100599)
and very effective
Gefitinib 3-Methyladenine Y-27632 primes human induced pluripotentGefitinib (ZD1839) is a potent, selective and orally active EGFR tyrosine kinase inhibitor with an IC50 of 33 nM. Gefitinib selectively inhibits EGF stimulated tumor cell growth (IC50 of 54 nM) and that blocks EGF stimulated EGFR autophosphorylation in tumor cells. Gefitinib also induces autophagy and cell apoptosis, which can be used for cancer related research, such as Lung cancer and breast cancer .